Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia

BACKGROUND: A post hoc analysis from a multiphase trial with open-label transition and maintenance phases, a double-blind relapse prevention phase, and an optional open-label extension examined the long-term tolerability with continuous once-monthly injectable paliperidone palmitate 39, 78, 117, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Sliwa, Jennifer Kern, Bossie, Cynthia A, Fu, Dong-Jing, Turkoz, Ibrahim, Alphs, Larry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431970/
https://www.ncbi.nlm.nih.gov/pubmed/22956873
http://dx.doi.org/10.2147/NDT.S32581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431970/
https://www.ncbi.nlm.nih.gov/pubmed/22956873
http://dx.doi.org/10.2147/NDT.S32581

Ejemplares similares